Livedoid Vasculopathy: A Review of 5 Clinical Cases

  • Rui Pedro Santos Interno de Serviço de Dermatovenereologia, Hospital de Braga, Braga, Portugal
  • Olga Ferreira Especialista de Serviço de Dermatovenereologia, Hospital de Braga, Braga, Portugal
  • Celeste Brito Especialista de Serviço de Dermatovenereologia, Hospital de Braga, Braga, Portugal
Keywords: Arterial Occlusive Diseases, Leg Ulcer, Livedo Reticularis, Skin Ulcer


Livedoid vasculopathy is an unusual thrombo-occlusive dermatosis that manifests with punctiform erythemato-purpuric lesions and extremely painful ulcers, preferably in the lower third of the legs. We report five patients with livedoid vasculopathy, three men and two women, aged between 24 and 54 years, with no relevant personal background. The diagnosis was confirmed by biopsy in four cases. Study of thrombophilias revealed heterozygosity of the MTHFR gene in two cases. Treatment was diversified and included among others, venothropics, anticoagulants, antithrombotics, immunosuppressants and intravenous immunoglobulin. Only one patient has unsatisfactory control of the disease. Livedoid vasculopathy etiopathogenesis remains uncertain. It may occur in the context of hereditary or acquired thrombophilia, autoimmunity or neoplasms. These changes should be excluded, but most cases remain idiopathic, which contributes to the therapeutic difficulty. The authors intend to emphasize the importance of the Dermatologist in the diagnosis of a probably under-recognized disease that causes significant morbidity.


Download data is not yet available.


Criado PR, Rivitti EA, Sotto MN, Valente NY, Aoki

V, Carvalho JF, et al. Livedoid vasculopathy: an intringuing

cutaneous disease. An Bras Dermatol.


Poletti NM, Moreno González JL, Santacruz Torres

A. Vasculopatía livedoide: significado actual. Comunicación

de dos casos. Dermatología Rev Mex.


Papi M, Didona B, De Pita O, Frezzolini A, Di Giulio S,

De Matteis W, et al. Livedo vasculopathy vs small vessel

cutaneous vasculitis: cytokine and platelet P-selectin studies.

Arch Dermatol. 1998;134:447-52.

Feldaker M, Hines EA Jr., Kierland RR. Livedo reticularis

with summer ulcerations. AMA Arch Derm.


Di Giacomo TB, Hussein TP, Souza DG, Criado PR. Frequency

of thrombophilia determinant factors in patients

with livedoid vasculopathy and treatment with anticoagulant

drugs--a prospective study. J Eur Acad Dermatol

Venereol. 2010;24:1340-6.

Gray HR, Graham JH, Johnson W, Burgoon CF Jr.

Atrophie blanche: periodic painful ulcers of lower extremities.

A clinical and histopathological entity. Arch

Dermatol. 1966;93:187-93.

Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado

PR, et al. Livedoid vasculopathy: an in-depth analysis

using a modified Delphi approach. J Am Acad Dermatol.

;69:1033-42 e1.

Alix JJ, Hadjivassiliou M, Ali R, Slater D, Messenger AG,

Rao DG. Sensory ganglionopathy with livedoid vasculopathy

controlled by immunotherapy. Muscle Nerve.


Toth C, Trotter M, Clark A, Zochodne D. Mononeuropathy

multiplex in association with livedoid vasculitis.

Muscle Nerve. 2003;28:634-9.

Kim JE, Park SY, Sinn DI, Kim SM, Hong YH, Park KS, et

al. Ischemic neuropathy associated with livedoid vasculitis.

J Clin Neurol. 2011;7:233-6.

Maessen-Visch MB, Koedam MI, Hamulyak K,

Neumann HA. Atrophie blanche. Int J Dermatol.


Kutzner GH. Therapeutic use of low molecular weight

heparin for capillaritis alba. Phlebologie. 2008;37:259–

Woo KY, Abbott LK, Librach L. Evidence-based approach

to manage persistent wound-related pain. Curr Opin

Support Palliat Care. 2013;7:86-94.

Hairston BR, Davis MD, Pittelkow MR, Ahmed I. Livedoid

vasculopathy: further evidence for procoagulant pathogenesis.

Arch Dermatol. 2006;142:1413-8.

Deng A, Gocke CD, Hess J, Heyman M, Paltiel M, Gaspari

A. Livedoid vasculopathy associated with plasminogen

activator inhibitor-1 promoter homozygosity

(4G/4G) treated successfully with tissue plasminogen

activator. Arch Dermatol. 2006;142:1466-9.

Tuchinda C, Leenutaphong V, Sudtim S, Lim HW. Refractory

livedoid vasculitis responding to PUVA: a report

of four cases. Photodermatol Photoimmunol Photomed.


Kreuter A, Gambichler T, Breuckmann F, Bechara FG,

Rotterdam S, Stucker M, et al. Pulsed intravenous immunoglobulin

therapy in livedoid vasculitis: an open trial

evaluating 9 consecutive patients. J Am Acad Dermatol.


Yang CH, Ho HC, Chan YS, Liou LB, Hong HS, Yang LC.

Intractable livedoid vasculopathy successfully treated

with hyperbaric oxygen. Br J Dermatol. 2003;149:647-

Rampf J, Sunderkotter C, Hirschfeld G, Scharffetter-

-Kochanek K, Weiss JM. Methylenetetrahydrofolate

reductase polymorphism associated with moderate

hyperhomocysteinaemia in a patient with livedo vasculopathy:

treatment with vitamin supplementation

and low molecular weight heparin. Br J Dermatol.


How to Cite
Santos, R. P., Ferreira, O., & Brito, C. (2018). Livedoid Vasculopathy: A Review of 5 Clinical Cases. Journal of the Portuguese Society of Dermatology and Venereology, 76(3), 287-294.
Original Articles